BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9649556)

  • 1. Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination.
    Mattsson A; Lönroth H; Quiding-Järbrink M; Svennerholm AM
    J Clin Invest; 1998 Jul; 102(1):51-6. PubMed ID: 9649556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different routes of vaccination for eliciting antibody responses in the human stomach.
    Johansson EL; Bergquist C; Edebo A; Johansson C; Svennerholm AM
    Vaccine; 2004 Feb; 22(8):984-90. PubMed ID: 15161075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human gastric B cell responses can be induced by intestinal immunisation.
    Quiding-Järbrink M; Lönroth H; Ahlstedt I; Holmgren J; Svennerholm AM
    Gut; 2001 Oct; 49(4):512-8. PubMed ID: 11559648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects.
    Mattsson A; Quiding-Järbrink M; Lönroth H; Hamlet A; Ahlstedt I; Svennerholm A
    Infect Immun; 1998 Jun; 66(6):2705-12. PubMed ID: 9596737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa.
    Lundgren A; Trollmo C; Edebo A; Svennerholm AM; Lundin BS
    Infect Immun; 2005 Sep; 73(9):5612-9. PubMed ID: 16113278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S; Hiratsuka T; Suzuki K; Kusunoki M; Wada K; Miyake K; Ohashi K; Shimizu M; Takahashi H; Gudis K; Kato S; Tsukui T; Sakamoto C
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
    Schmausser B; Eck M; Greiner A; Lührs H; Vollmers HP; Müller-Hermelink HK
    Virchows Arch; 2002 Aug; 441(2):143-7. PubMed ID: 12189503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.
    Quiding M; Nordström I; Kilander A; Andersson G; Hanson LA; Holmgren J; Czerkinsky C
    J Clin Invest; 1991 Jul; 88(1):143-8. PubMed ID: 1905327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immune response to Helicobacter pylori and cytotoxic mechanism.
    Sugiyama T; Yabana T; Yachi A
    Scand J Gastroenterol Suppl; 1995; 208():30-2. PubMed ID: 7777802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mucosal B- and T-cell responses in Helicobacter pylori-infected subjects in a developing and a developed country.
    Bhuiyan TR; Qadri F; Bardhan PK; Ahmad MM; Kindlund B; Svennerholm AM; Lundgren A
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):70-9. PubMed ID: 18625017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
    Kubota E; Joh T; Tanida S; Sasaki M; Kataoka H; Watanabe K; Itoh K; Oshima T; Ogasawara N; Togawa S; Wada T; Yamada T; Mori Y; Fujita F; Shimura T; Ohara H; Isaka M; Yasuda Y; Itoh M
    Helicobacter; 2005 Aug; 10(4):345-52. PubMed ID: 16104951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients.
    Quiding-Järbrink M; Sundström P; Lundgren A; Hansson M; Bäckström M; Johansson C; Enarsson K; Hermansson M; Johnsson E; Svennerholm AM
    Clin Immunol; 2009 Jun; 131(3):463-71. PubMed ID: 19249247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
    Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local and systemic immune responses in humans against Helicobacter pylori antigens from homologous and heterologous strains.
    Tinnert A; Mattsson A; Bölin I; Dalenbäck J; Hamlet A; Svennerholm AM
    Microb Pathog; 1997 Nov; 23(5):285-96. PubMed ID: 9405206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell receptor T-lymphocytes in normal and Helicobacter pylori-infected human gastric mucosa.
    O'Keeffe J; Gately CM; O'Donoghue Y; Zulquernain SA; Stevens FM; Moran AP
    Helicobacter; 2008 Dec; 13(6):500-5. PubMed ID: 19166415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative detection of secretory immunoglobulin A to Helicobacter pylori in gastric juice: antibody capture enzyme-linked immunosorbent assay.
    Hayashi S; Sugiyama T; Hisano K; Awakawa T; Kurokawa I; Yachi A; Isogai H; Isogai E; Yokota K; Hirai Y; Oguma K; Fujii N
    J Clin Lab Anal; 1996; 10(2):74-7. PubMed ID: 8852358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.
    Malfertheiner P; Schultze V; Rosenkranz B; Kaufmann SH; Ulrichs T; Novicki D; Norelli F; Contorni M; Peppoloni S; Berti D; Tornese D; Ganju J; Palla E; Rappuoli R; Scharschmidt BF; Del Giudice G
    Gastroenterology; 2008 Sep; 135(3):787-95. PubMed ID: 18619971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.